Thomas R. Cannell - Insider Trading & Ownership

Entity
Individual
Location
C/O Sesen Bio, Inc., 245 First Street, Suite 1800, Cambridge, MA
Summary
The estimated net worth of Thomas R. Cannell is at least $395K dollars as of March 6, 2023. Thomas R. Cannell is the President and CEO, Director of Sesen Bio, Inc. and owns shares of Carisma Therapeutics Inc. (CARM) stock worth about $395K.
All Insider Reports
All Insider Reports

Ownership of Thomas R. Cannell

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CARM Carisma Therapeutics Inc. President and CEO, Director $395K Mar 2, 2023

Insider Transactions Reported by Thomas R. Cannell:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.